Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514578 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
A Phase 1 study, sponsored by Trevena.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01514578 is a Phase 1 study that has completed, run by Trevena. The registered enrollment target is 74 participants.
The verdict
NCT01514578, a Phase 1 study, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.
Interventions
- DRUG Dextrose in Water
- DRUG TRV130A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01514578
The ClinicalTrials.gov registry entry for NCT01514578 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dextrose in Water is the first listed.
NCT01514578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01514578 about?
NCT01514578 is a clinical study titled "Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males". This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.
What is the current status of trial NCT01514578?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01514578?
The interventions under investigation include: Dextrose in Water (DRUG), TRV130A (DRUG).
Who is sponsoring clinical trial NCT01514578?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.